Novel susceptibility pathways and drug targets for psychosis

Researcher: 
Rixt van der Veen

Postdoc on the TI-Pharma project “Novel susceptibility pathways and drug targets for psychosis”
In this project, rodent ‘psychosis’ models are used displaying differences in susceptibility to acute or chronic dopamine receptor stimulation. We try to identify novel pathways affected in key brain areas of susceptible and resistant individuals.

23/02/2010